News

Filter

1 to 9 of 95862 results

Hikma's profits boosted in first half by good injectables sales

Hikma's profits boosted in first half by good injectables sales

20-08-2014

Revenue for Jordanian drugmaker Hikma Pharmaceuticals in the first half of 2014 rose 16% following a…

FinancialGenericsHikma PharmaceuticalsJordan

Eisai submits marketing authorization to the EU for Fycompa in new seizure indication

Eisai submits marketing authorization to the EU for Fycompa in new seizure indication

20-08-2014

Japanese drug major Eisai has submitted a marketing authorization application to the European Commission…

BrainCNS DiseasesEisaiEpilepsyFycompaJapanPartial-onset seizuresPharmaceuticalPrimary generalized tonic-clonic seizuresRegulationSeizure types

Novartis signs agreement with TB Alliance for development of its tuberculosis compounds

Novartis signs agreement with TB Alliance for development of its tuberculosis compounds

20-08-2014

Swiss drug major Novartis has signed an exclusive global licensing agreement with the Global Alliance…

Antibiotics and Infectious diseasesNovartisPharmaceuticalResearchSwitzerlandTB AllianceTropical diseasesTuberculosis

Roche to partner with the Garvan Institute in genomics research

Roche to partner with the Garvan Institute in genomics research

20-08-2014

Swiss drug major Roche and the Garvan Institute of Medical Research are to collaborate in the development…

AustraliaBiotechnologyDNA sequencingGarvan InstituteGeneticsGenomics technologiesJohn MattickResearchRocheSwitzerland

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

20-08-2014

UK drugs watch dog the National Institute for Health and Care Excellence (NICE) has issued final draft…

BiotechnologyCelgene Corp.Myelodysplastic syndromesOncologyPricingRegulationRevlimidUK

Depomed prevails in Gralise ANDA litigation with Actavis

Depomed prevails in Gralise ANDA litigation with Actavis

20-08-2014

US drug maker Depomed saw its shares climb more than 12% to $14.76 on Tuesday, on the news that the firm…

ActavisDepomedGraliseLegalNeurologicalPatentsPharmaceuticalUSA

Genzyme’s Cerdelga gets FDA approval for Gaucher disease

Genzyme’s Cerdelga gets FDA approval for Gaucher disease

20-08-2014

The US Food and Drug Administration late yesterday approved Cerdelga (eliglustat) for the long-term treatment…

ActelionBiotechnologyCerdelgaCerezymeGenzymeRare diseasesRegulationSanofiUSAZavesca

Novartis to start production of Tasigna in Russia

Novartis to start production of Tasigna in Russia

19-08-2014

Russia’s largest drugmaker Pharmstandard has signed an agreement with Swiss pharma major Novartis on…

CancerCytokinesHealth Medical PharmaIgor KrylovMajorNovartisOncologyPharmaceuticalPharmstandardProductionRussiaTasigna

1 to 9 of 95862 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top